{
  "docId": "019de073-a7b5-7720-904b-d55cb9d2acd2",
  "docSlug": "ff09795c4205ae982e453519f0f2447b",
  "documentTitle": "Bionomics | Investor Presentation Deck | 59 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 54,
  "pageCount": 59,
  "prevPage": 53,
  "nextPage": 55,
  "slideType": "customer_journey",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "Includes qualitative testimonials from psychiatrists to support the adoption thesis.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a7b5-7720-904b-d55cb9d2acd2/54",
  "deckHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2",
  "deckJsonHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2.json",
  "deckAnchorHref": "/decks/019de073-a7b5-7720-904b-d55cb9d2acd2#slide-54",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.54,
        "x": 0.04,
        "y": 0.58
      },
      "kind": "list",
      "text": "Long-Term Expansion: Because social anxiety disorder is a chronic disease that psychiatrists believe must be treated with chronic pharmacotherapy and psychotherapy, there is a strong preference to transition to using BNC210 on a daily basis.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ed78585-b9cf-4227-bf22-c181a9e36598",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.54,
        "x": 0.04,
        "y": 0.24
      },
      "kind": "list",
      "text": "Initial Adoption: Upon initial approval based on a public speaking challenge trial design, psychiatrists would use 210 in place of benzos and beta blockers due to its strong safety and efficacy.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77171860-32a2-477d-9d5f-3b80beb49064",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.35,
        "x": 0.61,
        "y": 0.47
      },
      "kind": "quote",
      "text": "I would prefer more of a chronic trial design, but I wouldn’t be too concerned about patients increasing from PRN to daily use. Initially I think patients would take it 2 or 3 times a week... – Psychiatrist, PA",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22f775e2-5474-4a97-ba49-7f3b28488d4f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.35,
        "x": 0.61,
        "y": 0.26
      },
      "kind": "quote",
      "text": "In a perfect world where cost was not an issue, I would like you use this right out of the gate. It is strongly needed. It’s not a ‘me too’ product. – Psychiatrist, TN",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f5b2f8d-016a-4369-bdb4-9261e547139a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.61,
        "y": 0.71
      },
      "kind": "quote",
      "text": "I would probably use this in place of a benzo at the onset. I wouldn’t see a reason to limit use. You have to remember the SSRIs provide benefit on co-morbidities for a lot of these patients. – Psychiatrist, MD",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "547cc7de-21f3-48c2-96c2-89930f5d40ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.15,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: Bluestar Primary Physician Interviews (n=13, March 2022)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ac0c47f-0581-4fb8-a7c9-be506ed8645c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.92,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "BNC210 usage is expected to begin as PRN, transitioning to chronic daily dosing over time, which is how physicians strongly prefer to manage the condition",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e03b24a-7095-427d-869c-de4857822847",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.44,
        "x": 0.28,
        "y": 0.15
      },
      "kind": "title",
      "text": "BNC210 Social Anxiety Disorder Anticipated Utilization",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80b07071-fec8-43c1-be75-d8277e80f300",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Customer journey map",
      "slug": "customer-journey-map",
      "agent": null,
      "layer": "slide",
      "matchId": "0802899a-3475-42f9-a8b6-339c5193910a",
      "evidence": "BNC210 usage is expected to begin as PRN, transitioning to chronic daily dosing over time",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "customer-journey-map",
      "slug": null,
      "matchId": "33455656-7111-49ea-b1eb-3261a3cebc29",
      "evidence": "The slide maps the progression of product usage from initial adoption to long-term expansion.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}